Hormone Therapy in Women’s 50s Linked to 23% Lower Dementia Risk

Recent research from the UK Biobank suggests that women who start common hormone replacement therapy (HRT) in their early 50s could see a significant drop in the likelihood of developing Alzheimer’s disease and other forms of dementia.

Study Design and Key Findings

The study examined data from thousands of participants, focusing on those who began HRT between the ages of 46 and 56. Researchers found a 23% reduction in dementia risk among this group compared to women who did not use HRT during that period.

What This Means for Women in Their 50s

While the findings are promising, experts caution that hormone therapy is not a universal solution. Individual health profiles, medical history, and risk factors should guide any decision about starting or continuing HRT. Consulting a healthcare provider remains essential.

Broader Implications for Dementia Prevention

These results add to a growing body of evidence that timing and type of hormone therapy may influence long‑term brain health. Further research is needed to understand the mechanisms behind the protective effect and to determine optimal treatment protocols.

Source: Fox News Health

Watch and listen free on JASTORM – Follow radio and video broadcasts free in the JASTORM app with your free account.